[1]
L. N. Bedoya-Trujillo and P. N. Bedoya-Trujillo, “Case report: pembrolizumab-induced Type 1 diabetes mellitus in a patient with lung adenocarcinoma”, rcedm, vol. 7, no. 3, pp. 188–192, Mar. 2021.